Activities and events

Activities and events conducted by IRA members in past 3 months Conversations in Osteoporosis: Lessons from the clinic organized on 12th January 2024 at BVP, Pune. -Kavita Krishna, Pune Talk on Prescription Errors in Rheumatology and artwork by an MBBS student at DDMCH, Keonjhar, Odisha. -Debasis Patro, Bhubaneswar Osteoporosis Dialogues on 14th January 2024 at […]

Work-teaching Balance: A Young Rheumatologist`s Perspective

Sanket Shah MD, DMConsultant Rheumatologist and Immunologist, RheumaCare, AhmedabadGCS Medical College, Ahmedabad Balancing acts in life often feel as mythical as unicorns—except for the bank balance. My journey, one of a young rheumatologist, may not mirror everyone’s reality, yet it echoes the diverse tapestry we all navigate. This narrative, raw and honest, captures a snapshot of […]

An ode to Dr Debashish Danda: The life of a remarkable rheumatologist

The Trailblazer from Tripura: On a Path Less Trodden The medical fraternity is still reeling from the shock demise of Dr Debashish Danda, MBBS, MD, DM, FRCP, a luminary in the field of rheumatology and clinical immunology, on February 24, 2024, in a harrowing vehicle mishap. A distinguished professor of medicine and rheumatology, Dr Danda […]

IRA Secretary’s Message

Vinod Ravindran MD, MRCP (UK), MSc-Rheumatology (King’s College, London, UK), CCT-Rheumatology (UK), MRCP-Rheumatology (UK), FRCP (Edin)Director, Centre for Rheumatology, Calicut, Kerala Dear Colleagues, We are all very sad by the untimely demise of our beloved Prof Debashish Danda. Danda sir has left a rich legacy for us in the IRA through his years of hard work. We […]

From the Editor

Vinod Ravindran MD, MRCP (UK), MSc-Rheumatology (King’s College, London, UK), CCT-Rheumatology (UK), MRCP-Rheumatology (UK), FRCP (Edin)Director, Centre for Rheumatology, Calicut, Kerala Dear Colleagues, I hope you will like the IRA e-newsletter’s first issue of this year. I thank all the members for their appreciation and constructive feedback on the previous issues. Our editorial board has worked collectively […]

Quarter in review: Clinical Sciences

Preksha Dwivedi MD, DM Associate Professor, Department of Medicine, Gandhi Medical College, Bhopal Study in focus 1: Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: long term efficacy and safety [1]Bimekizumab (BKZ) is a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A. The benefits of dual neutralisation were demonstrated clinically in […]

Fitness = Quality of Life

Atul GattaniConsultant Rheumatologist, Navi Mumbai Arthritis and Rheumatism Centre, Vashi Apollo Hospital, Navi Mumbai I have been into fitness not for long, but for the past 10 years, and with time I have realised its importance. It plays a pivotal role in improving the quality of life. Fitness was not given importance in the early years […]

Close to my heart: my favourite five books

Sapan Pandya MD, DMRheumaCare Clinics, Ahmedabad Reading, as a hobby, is slowly vanishing and we will have to endeavour to keep it running. One of the ways is to have book reviews once in a while and also sessions on ‘humanities and medicine’. Following are the top five books that I’ve read that I would […]

Quarter in review – Basic science

Taral P Parikh MD, DNB RheumatologyConsultant Rheumatologist, Zydus Hospital/ Rheumacare Clinic, Ahmedabad Study in focus 1: Proteomic and genomic profiling of plasma exosomes from patients with Ankylosing spondylitis (AS)1. Study Synopsis The pathogenesis of ankylosing spondylitis is evolving. The ability of exosomes to transport miRNAs across cells and alter the phenotype of recipient cells has […]

Quarter in Review: Paediatric Rheumatology

Devang B PandyaConsultant Paediatric Rheumatologist & Immunologist, Krish Superspeciality Clinic, Ahmedabad Study In Focus 1: Janus Kinase Inhibitor, Tofacitinib, In Refractory Juvenile Dermatomyositis: A Retrospective Multi‑Central Study In China1 Recently, there has been an emerging interest of interferon in the pathogenesis of Juvenile Dermatomyositis (JDM). JAK inhibitors have yielded satisfactory responses in treating interferonopathies and refractory […]